The Board of the directors of Zhaoke Ophthalmology Limited announced that the Board has established the Investment Committee and Executive Committee on 26 November 2021 to handle affairs relating to the investment aspects of the company, further regulate the governance structure of the Board and safeguard the interests of shareholders. Mr. Wong Hin Wing (Company's independent non-executive) has been appointed as the chairman of the Investment Committee, and Dr. Li Xiaoyi (Company's Executive Director) and Prof. Lo Yuk Lam (Company's independent non-executive) have been appointed as the members of the Investment Committee, all with effect from 26 November 2021. Dr. Li Xiaoyi (Company's Executive Director) has been appointed as the chairman of the Executive Committee, and Mr. Dai Xiangrong (Company's Executive Director), Dr. Lau Lit Fui (Company's Chief Operating Officer), Ms. Feng Xinyan (Company's Chief Financial Officer) and Dr. Albert Tsai Jr. (Company's Chief Medical Officer) have been appointed as the members of the Executive Committee, all with effect from 26 November 2021. The Board also approved the terms of reference of both committee.